Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

732 Articles

Jon C. Ogg | May 1, 2013 at 10:45 AM EDT

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Biotech stocks come and go as far as the flavor of the day for investors. While many of these companies…

Paul Ausick | Apr 23, 2013 at 4:07 PM EDT

24/7 Wall St. Closing Bell — April 23, 2013: Flash Crash Has No Impact on Rising Stocks

U.S. equity markets opened higher this morning despite low flash PMI readings from the eurozone. Germany’s manufacturing PMI reading was…

Paul Ausick | Apr 22, 2013 at 4:03 PM EDT

24/7 Wall St. Closing Bell — April 22, 2013: Markets Close Higher After Rocky Start

U.S. equity markets opened higher this morning, but struggled to stay in positive territory for most of the morning. There…

Paul Ausick | Apr 17, 2013 at 4:05 PM EDT

24/7 Wall St. Closing Bell — April 17, 2013: Markets Open Down, Track Lower All Day

U.S. equity markets opened lower this morning following a downturn in Europe and mixed markets in Asia. Data releases were…

Jon C. Ogg | Apr 17, 2013 at 8:45 AM EDT

Top Wall Street Analyst Upgrades and Positive Views

Jon OggInvestors and traders are always on the lookout for fresh research ideas from Wall St. that will lead to…

Paul Ausick | Mar 27, 2013 at 4:06 PM EDT

24/7 Wall St. Closing Bell — March 27, 2013: Markets Close Mixed After Low Start (VMW, GOOG, AOL, GIS, ORCL, MFRM, SAI, XONE, PAYX, SNX, TXI, END, FINL, GME, MOS, BBRY, WGO, CLF, FB, GILD)

U.S. equity markets opened lower this morning following a stack of poor reports on the Italian economy. New industrial orders…

Jon C. Ogg | Mar 25, 2013 at 8:55 AM EDT

Top Stocks to Buy From the Merrill Lynch Core Portfolio (BAC, SPY, V, JPM, GILD, OXY, HON, HD, WMT)

Typically, large Wall St. firms suggest a broad asset allocation portfolio for their clients. Within the portfolio, they use a…

Jon C. Ogg | Mar 14, 2013 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades (AMZN, DOX, AAPL, MT, CINF, ETFC, EBAY, GILD, HTWR, IPAR, SNDK, VMW, WFC)

Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from select Wall St. research calls.…

Jon C. Ogg | Mar 12, 2013 at 8:25 AM EDT

UBS Picks the Eight Top Stocks to Buy Now (F, HD, SBUX, GILD, MCK, MYL, CMI, LLTC)

For anybody that has missed the big stock market rally, it can be very disheartening to watch as anchors on…

Jon C. Ogg | Mar 1, 2013 at 11:10 AM EST

Daily ETF Folly: Why There Is No True Biotech Representation in ETFs

Thinkstock24/7 Wall St. is taking a daily aim at the world exchange-traded funds (ETFs). Many are great, and many are…

Jon C. Ogg | Feb 28, 2013 at 12:50 PM EST

ETF Folly: Biotech ETFs, Nothing but Confusion

Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or…

Jon C. Ogg | Feb 25, 2013 at 8:30 AM EST

Top Analyst Upgrades and Downgrades (ABAX, ATVI, AFFY, AKAM, AIG, ETN, GILD, HNZ, IP, OXY, OMG, OC, PAAS, SWY, TTWO, TEVA, TPH, VMW)

Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Abaxis Inc.…

Jon C. Ogg | Feb 19, 2013 at 8:20 AM EST

Top Analyst Upgrades and Downgrades (APA, BAC, BRK-A, CLF, CSTR, CREE, CY, FITB, GILD, GFI, HAL, HIG, HBC, PHG, PVH, STI, UBS, VECO, WFC)

Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Apache…

Jon C. Ogg | Jan 9, 2013 at 7:27 AM EST

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the…

Jon C. Ogg | Dec 20, 2012 at 2:57 PM EST

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

The largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in 2013.…

1 … 40 41 42 43 44 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

24/7 Wall St. Closing Bell — April 23, 2013: Flash Crash Has No Impact on Rising Stocks

24/7 Wall St. Closing Bell — April 22, 2013: Markets Close Higher After Rocky Start

24/7 Wall St. Closing Bell — April 17, 2013: Markets Open Down, Track Lower All Day

Top Wall Street Analyst Upgrades and Positive Views

24/7 Wall St. Closing Bell — March 27, 2013: Markets Close Mixed After Low Start (VMW, GOOG, AOL, GIS, ORCL, MFRM, SAI, XONE, PAYX, SNX, TXI, END, FINL, GME, MOS, BBRY, WGO, CLF, FB, GILD)

Top Stocks to Buy From the Merrill Lynch Core Portfolio (BAC, SPY, V, JPM, GILD, OXY, HON, HD, WMT)

Top Analyst Upgrades and Downgrades (AMZN, DOX, AAPL, MT, CINF, ETFC, EBAY, GILD, HTWR, IPAR, SNDK, VMW, WFC)

UBS Picks the Eight Top Stocks to Buy Now (F, HD, SBUX, GILD, MCK, MYL, CMI, LLTC)

Daily ETF Folly: Why There Is No True Biotech Representation in ETFs

ETF Folly: Biotech ETFs, Nothing but Confusion

Top Analyst Upgrades and Downgrades (ABAX, ATVI, AFFY, AKAM, AIG, ETN, GILD, HNZ, IP, OXY, OMG, OC, PAAS, SWY, TTWO, TEVA, TPH, VMW)

Top Analyst Upgrades and Downgrades (APA, BAC, BRK-A, CLF, CSTR, CREE, CY, FITB, GILD, GFI, HAL, HIG, HBC, PHG, PVH, STI, UBS, VECO, WFC)

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Gilead Sciences : GILD

All Gilead Sciences Articles

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

24/7 Wall St. Closing Bell — April 23, 2013: Flash Crash Has No Impact on Rising Stocks

24/7 Wall St. Closing Bell — April 22, 2013: Markets Close Higher After Rocky Start

24/7 Wall St. Closing Bell — April 17, 2013: Markets Open Down, Track Lower All Day

Top Wall Street Analyst Upgrades and Positive Views

24/7 Wall St. Closing Bell — March 27, 2013: Markets Close Mixed After Low Start (VMW, GOOG, AOL, GIS, ORCL, MFRM, SAI, XONE, PAYX, SNX, TXI, END, FINL, GME, MOS, BBRY, WGO, CLF, FB, GILD)

Top Stocks to Buy From the Merrill Lynch Core Portfolio (BAC, SPY, V, JPM, GILD, OXY, HON, HD, WMT)

Top Analyst Upgrades and Downgrades (AMZN, DOX, AAPL, MT, CINF, ETFC, EBAY, GILD, HTWR, IPAR, SNDK, VMW, WFC)

UBS Picks the Eight Top Stocks to Buy Now (F, HD, SBUX, GILD, MCK, MYL, CMI, LLTC)

Daily ETF Folly: Why There Is No True Biotech Representation in ETFs

ETF Folly: Biotech ETFs, Nothing but Confusion

Top Analyst Upgrades and Downgrades (ABAX, ATVI, AFFY, AKAM, AIG, ETN, GILD, HNZ, IP, OXY, OMG, OC, PAAS, SWY, TTWO, TEVA, TPH, VMW)

Top Analyst Upgrades and Downgrades (APA, BAC, BRK-A, CLF, CSTR, CREE, CY, FITB, GILD, GFI, HAL, HIG, HBC, PHG, PVH, STI, UBS, VECO, WFC)

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings